CA
EW icon

CoreCap Advisors’s Edwards Lifesciences EW Stock Holding History

CoreCap Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Buy
260
+32
+14% +$2.68K ﹤0.01% 1732
2026
Q1 		$18.3K Sell
228
-460
-67% -$37.9K ﹤0.01% 1703
2025
Q4 		$58.7K Sell
688
-590
-46% -$48.4K ﹤0.01% 1251
2025
Q3 		$99.4K Buy
1,278
+109
+9% +$8.52K ﹤0.01% 1040
2025
Q2 		$91.4K Buy
1,169
+920
+369% +$68.6K ﹤0.01% 1017
2025
Q1 		$18K Sell
249
-2
-0.8% -$143 ﹤0.01% 1580
2024
Q4 		$18.6K Sell
251
-116
-32% -$8.12K ﹤0.01% 1562
2024
Q3 		$24.2K Buy
+367
New +$26.7K ﹤0.01% 1469
2024
Q2 		– Sell
-196
Closed -$18.7K – 1894
2024
Q1 		$18.7K Buy
+196
New +$16.5K ﹤0.01% 1506
2022
Q4 		$43.6K Buy
+585
New +$45.1K ﹤0.01% 1033
2022
Q3 		– Sell
-1,073
Closed -$102K – 1005
2022
Q2 		$102K Buy
+1,073
New +$111K 0.01% 680
2022
Q1 		– Sell
-2,438
Closed -$316K – 1012
2021
Q4 		$316K Buy
+2,438
New +$284K 0.02% 434

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

CoreCap Advisors's EW Position: Q2 2026 in Review

CoreCap Advisors increased its Edwards Lifesciences (EW) stake by 14% in Q2 2026, buying an estimated $2.68K and bringing the position to 260 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1732.

CoreCap Advisors first reported a position in EW in Q4 2021 and has held it in 12 quarters since. The position peaked at $316K in Q4 2021. 287 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • CoreCap Advisors held 260 shares of Edwards Lifesciences worth $23.5K as of Q2 2026.
  • CoreCap Advisors bought 32 Edwards Lifesciences shares in Q2 2026, an estimated $2.68K.
  • Edwards Lifesciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1732 holding.
  • CoreCap Advisors first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's Edwards Lifesciences position peaked at $316K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.